Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofia Perea

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Diabetology & Metabolic Syndrome|July 23, 2020
Gender differences in quality of life in adults with long-standing type 1 diabetes mellitusAna María Castellano-Guerrero, Raquel Guerrero, Desireé Ruiz-Aranda, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasisSofia Perea, José L López-Ribot, Brian L Wickes, et al.
Cancer Research|December 18, 2004
An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitorsMaria L Amador, Darin Oppenheimer, Sofia Perea, et al.
Journal for Immunotherapy of Cancer|November 18, 2021
Empirical identification and validation of tumor-targeting T cell receptors from circulation using autologous pancreatic tumor organoidsQingda Meng, Shanshan Xie, G Kenneth Gray, et al.
Molecular Cancer Therapeutics|June 6, 2020
Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor CellsSpas Dimitrov-Markov, Javier Perales-Patón, Bruno Bockorny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2Teresa Macarulla, Roberto Pazo-Cid, Carmen Guillén-Ponce, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2020
OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor ModelsMyriam Fabre, Cristina Ferrer, Saioa Domínguez-Hormaetxe, et al.
Elife|December 18, 2024
A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancerBruno Bockorny, Lakshmi Muthuswamy, Ling Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
A Large-Scale Proteomics Resource of Circulating Extracellular Vesicles for Biomarker Discovery in Pancreatic CancerBruno Bockorny, Lakshmi Muthuswamy, Ling Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2024
A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR TrialFrancesca Sarno, Jair Tenorio, Sofia Perea, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Diabetology & Metabolic Syndrome|July 23, 2020
Gender differences in quality of life in adults with long-standing type 1 diabetes mellitusAna María Castellano-Guerrero, Raquel Guerrero, Desireé Ruiz-Aranda, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasisSofia Perea, José L López-Ribot, Brian L Wickes, et al.
Cancer Research|December 18, 2004
An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitorsMaria L Amador, Darin Oppenheimer, Sofia Perea, et al.
Journal for Immunotherapy of Cancer|November 18, 2021
Empirical identification and validation of tumor-targeting T cell receptors from circulation using autologous pancreatic tumor organoidsQingda Meng, Shanshan Xie, G Kenneth Gray, et al.
Molecular Cancer Therapeutics|June 6, 2020
Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor CellsSpas Dimitrov-Markov, Javier Perales-Patón, Bruno Bockorny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2Teresa Macarulla, Roberto Pazo-Cid, Carmen Guillén-Ponce, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2020
OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor ModelsMyriam Fabre, Cristina Ferrer, Saioa Domínguez-Hormaetxe, et al.
Elife|December 18, 2024
A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancerBruno Bockorny, Lakshmi Muthuswamy, Ling Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
A Large-Scale Proteomics Resource of Circulating Extracellular Vesicles for Biomarker Discovery in Pancreatic CancerBruno Bockorny, Lakshmi Muthuswamy, Ling Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2024
A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR TrialFrancesca Sarno, Jair Tenorio, Sofia Perea, et al.
Pageof 3